企業プロフィール
Mirum Pharmaceuticals 株価・ニュース・カタリスト
- ティッカー:
- MIRM
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
96.72 USD (+0.43%)
終値
最終更新: 2026年8月24日
5.62B USD
時価総額
株価変動の要因
As of Aug 24, 2026, MIRM closed up 0.43% at $96.72. No new same-company headline was identified in the current news window.
企業概要
事業概要
Mirum Pharmaceuticals is a rare-disease company focused on cholestatic and liver disorders. Its commercial profile is built around specialized therapies for pediatric and orphan indications.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Mirum sits in specialty biopharma.
ビジネスモデルの特徴
The company combines product revenue with label expansion and pipeline growth in liver disease.
バイオ業界での位置付け
Mirum is a durable rare-disease name whose stock moves on commercial execution and franchise expansion.
今後のカタリスト
- Mirum's catalysts are Livmarli growth, liver-disease expansion, and any new rare-cholestatic label or commercial step that widens the franchise. The stock improves if the rare-disease base keeps compounding into a broader franchise.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。